Literature DB >> 23397471

Combined hepatocellular cholangiocarcinoma: a case report and review of literature.

Shailender Singh1, Subhankar Chakraborty, Neelima Bonthu, Stanley Radio, Shahid M Hussain, Aaron Sasson.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23397471     DOI： 10.1007/s10620-013-2585-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  30 in total

Review 1.  Origin of hepatocellular carcinoma: role of stem cells.

Authors:  Xiong-Zhi Wu; Dan Chen
Journal:  J Gastroenterol Hepatol       Date:  2006-07       Impact factor: 4.029

2.  Combined liver cell and bile duct carcinoma.

Authors:  R A ALLEN; J R LISA
Journal:  Am J Pathol       Date:  1949-07       Impact factor: 4.307

3.  A clinicopathological study on combined hepatocellular and cholangiocarcinoma.

Authors:  J Taguchi; O Nakashima; M Tanaka; T Hisaka; T Takazawa; M Kojiro
Journal:  J Gastroenterol Hepatol       Date:  1996-08       Impact factor: 4.029

4.  Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Jeong-Hoon Lee; Goh Eun Chung; Su Jong Yu; Sang Youn Hwang; Joon Suk Kim; Hwi Young Kim; Jung-Hwan Yoon; Hyo-Suk Lee; Nam-Joon Yi; Kyung-Suk Suh; Kuhn Uk Lee; Ja-June Jang; Yoon Jun Kim
Journal:  J Clin Gastroenterol       Date:  2011-01       Impact factor: 3.062

5.  The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma.

Authors:  C Panjala; D L Senecal; M D Bridges; G P Kim; R E Nakhleh; J H H Nguyen; D M Harnois
Journal:  Am J Transplant       Date:  2010-05       Impact factor: 8.086

6.  Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.

Authors:  Jin Hyoung Kim; Hyun-Ki Yoon; Gi-Young Ko; Dong Il Gwon; Cheol Soo Jang; Ho-Young Song; Ji Hoon Shin; Kyu-Bo Sung
Journal:  Radiology       Date:  2010-04       Impact factor: 11.105

Review 7.  Management of combined hepatocellular and cholangiocarcinoma.

Authors:  W T Kassahun; J Hauss
Journal:  Int J Clin Pract       Date:  2008-02-13       Impact factor: 2.503

8.  Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma.

Authors:  S Nakamura; S Suzuki; T Sakaguchi; A Serizawa; H Konno; S Baba; S Baba; H Muro
Journal:  Cancer       Date:  1996-10-15       Impact factor: 6.860

9.  A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions.

Authors:  H Yano; A Iemura; M Haramaki; S Momosaki; S Ogasawara; K Higaki; M Kojiro
Journal:  J Hepatol       Date:  1996-04       Impact factor: 25.083

10.  Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature.

Authors:  Yan-Ming Zhou; Jia-Mei Yang; Bin Wang; Feng Xu; Ying Tong; Dian-Qi Li
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2007-12
View more
  8 in total

1.  Debating the presentation, morphology, origin, and prognosis of a combined hepatocellular-cholangiocarcinoma.

Authors:  Laura Lorenzon; Paolo Castaldo; Andrea Bartolazzi; Simone Rossi Del Monte; Alessandra Camboni; Emanuela Pilozzi; Pier Federico Salvi; Pierfederico Salvi; Vincenzo Ziparo
Journal:  Dig Dis Sci       Date:  2013-05-22       Impact factor: 3.199

Review 2.  Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.

Authors:  Elizabeth M Brunt; Valerie Paradis; Christine Sempoux; Neil D Theise
Journal:  Hepat Oncol       Date:  2015-07-28

3.  Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma.

Authors:  Elisabetta Sagrini; Massimo Iavarone; Federico Stefanini; Francesco Tovoli; Sara Vavassori; Marco Maggioni; Matteo Renzulli; Veronica Salvatore; Horia Stefanescu; Massimo Colombo; Luigi Bolondi; Fabio Piscaglia
Journal:  United European Gastroenterol J       Date:  2018-11-22       Impact factor: 4.623

4.  IDH mutations in liver cell plasticity and biliary cancer.

Authors:  Supriya K Saha; Christine A Parachoniak; Nabeel Bardeesy
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Xiao-Wen Huang; Yang Huang; Li-da Chen; Zhu Wang; Zheng Yang; Jin-Ya Liu; Xiao-Yan Xie; Ming-De Lu; Shun-Li Shen; Wei Wang
Journal:  J Med Ultrason (2001)       Date:  2017-10-20       Impact factor: 1.314

6.  The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome.

Authors:  Scott Robertson; Omar Hyder; Rebecca Dodson; Suresh K Nayar; Justin Poling; Katie Beierl; James R Eshleman; Ming-Tseh Lin; Timothy M Pawlik; Robert A Anders
Journal:  Hum Pathol       Date:  2013-10-15       Impact factor: 3.466

7.  Rare Histological Variants of Liver Cancer and Their Management: A Single-Institution Experience.

Authors:  Brandon Swed; Omar Gandarilla; Kenrry Chiu; Karim H Halazun; Benjamin Samstein; Rhonda Yantiss; Gagandeep Brar
Journal:  Case Reports Hepatol       Date:  2021-04-21

8.  Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma.

Authors:  Zhiyu Li; Xiaolong Wu; Xinyu Bi; Yefan Zhang; Zhen Huang; Haizhen Lu; Hong Zhao; Jianjun Zhao; Jianguo Zhou; Muxing Li; Jianming Ying; Jianqiang Cai
Journal:  Chin J Cancer Res       Date:  2018-06       Impact factor: 5.087
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.